These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25274897)

  • 1. Naproxen effects on brain response to painful pressure stimulation in patients with knee osteoarthritis: a double-blind, randomized, placebo-controlled, single-dose study.
    Giménez M; Pujol J; Ali Z; López-Solà M; Contreras-Rodríguez O; Deus J; Ortiz H; Soriano-Mas C; Llorente-Onaindia J; Monfort J
    J Rheumatol; 2014 Nov; 41(11):2240-8. PubMed ID: 25274897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chondroitin sulfate on brain response to painful stimulation in knee osteoarthritis patients. A randomized, double-blind, placebo-controlled functional magnetic resonance imaging study.
    Monfort J; Pujol J; Contreras-Rodríguez O; Llorente-Onaindia J; López-Solà M; Blanco-Hinojo L; Vergés J; Herrero M; Sánchez L; Ortiz H; Montañés F; Deus J; Benito P
    Med Clin (Barc); 2017 Jun; 148(12):539-547. PubMed ID: 28237612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
    Schnitzer TJ; Kamin M; Olson WH
    Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen.
    Ekman EF; Gimbel JS; Bello AE; Smith MD; Keller DS; Annis KM; Brown MT; West CR; Verburg KM
    J Rheumatol; 2014 Nov; 41(11):2249-59. PubMed ID: 25274899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis.
    Mayorga AJ; Flores CM; Trudeau JJ; Moyer JA; Shalayda K; Dale M; Frustaci ME; Katz N; Manitpisitkul P; Treister R; Ratcliffe S; Romano G
    Scand J Pain; 2017 Oct; 17():134-143. PubMed ID: 28850367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Pain Reduction with fMRI BOLD Response in Osteoarthritis Patients Treated with Paracetamol: Randomized, Double-Blind, Crossover Clinical Efficacy Study.
    Yue Y; Collaku A
    Pain Med; 2018 Feb; 19(2):355-367. PubMed ID: 29025005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee.
    Schiff M; Minic M
    J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic modulation of hand pain in osteoarthritis: a double-blind placebo-controlled functional magnetic resonance imaging study using naproxen.
    Sanders D; Krause K; O'Muircheartaigh J; Thacker MA; Huggins JP; Vennart W; Massat NJ; Choy E; Williams SC; Howard MA
    Arthritis Rheumatol; 2015 Mar; 67(3):741-51. PubMed ID: 25533872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.
    Frakes EP; Risser RC; Ball TD; Hochberg MC; Wohlreich MM
    Curr Med Res Opin; 2011 Dec; 27(12):2361-72. PubMed ID: 22017192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
    Altman RD; Moskowitz R
    J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee- a subset analysis.
    Levy R; Khokhlov A; Kopenkin S; Bart B; Ermolova T; Kantemirova R; Mazurov V; Bell M; Caldron P; Pillai L; Burnett B
    Adv Ther; 2010 Dec; 27(12):953-62. PubMed ID: 20972845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
    Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
    J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the analgesic effect of lanepitant in patients with osteoarthritis pain.
    Goldstein DJ; Wang O; Todd LE; Gitter BD; DeBrota DJ; Iyengar S
    Clin Pharmacol Ther; 2000 Apr; 67(4):419-26. PubMed ID: 10801252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36.
    Svensson O; Malmenäs M; Fajutrao L; Roos EM; Lohmander LS
    Ann Rheum Dis; 2006 Jun; 65(6):781-4. PubMed ID: 16269428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A walking model to assess the onset of analgesia in osteoarthritis knee pain.
    Peeva E; Beals CR; Bolognese JA; Kivitz AJ; Taber L; Harman A; Smugar SS; Moskowitz RW
    Osteoarthritis Cartilage; 2010 May; 18(5):646-53. PubMed ID: 20175977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.